Effect of poly(adenosine diphosphate-ribose) polymerase inhibitors on neocarzinostatin-induced G2 delay in HeLa-S3

Related Experiment Videos

Cancer Research
|September 1, 1985
PubMed

Insights

Neocarzinostatin (NCS) stimulates poly(ADP-ribose) polymerase, but inhibiting this enzyme does not prevent NCS-induced G2 cell cycle delay. This suggests poly ADP-ribosylation is not directly involved in NCS-induced G2 arrest.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Neocarzinostatin (NCS) is an antitumor antibiotic that induces DNA strand breaks.
  • NCS stimulates poly(ADP-ribose) polymerase (PARP) activity in mammalian cells.
  • NCS causes temporary G2 cell cycle arrest, potentially linked to PARP activity.

Purpose of the Study:

  • To investigate the role of poly ADP-ribosylation in NCS-induced G2 cell cycle arrest.
  • To evaluate the effect of PARP inhibitors on NCS-induced polymerase activity and cell cycle progression.

Main Methods:

  • Synchronized HeLa cells were treated with NCS in the G2 phase.
  • Various poly(ADP-ribose) polymerase inhibitors (thymidine, 3-aminobenzamide, nicotinamide, theophylline, caffeine) were used.
  • Effects on NCS-induced polymerase activity and G2 delay were measured.

Main Results:

  • All tested inhibitors reduced NCS-induced polymerase activity.
  • Caffeine, theophylline, and thymidine reduced G2 delay, while 3-aminobenzamide and nicotinamide had minimal effect.
  • The order of G2 delay reduction was caffeine > theophylline > thymidine.

Conclusions:

  • Poly ADP-ribosylation of chromatin protein is not directly involved in the mechanism of NCS-induced G2 delay.
  • Caffeine's effect on G2 delay is likely independent of its PARP inhibitory activity.

Related Concept Videos